The rad30 cancer susceptibility gene
Carty, M.P. Glynn, M. Maher, M. Smith, T. Yao, J. Dixon, K. McCann, J. Rynn, L. Flanagan, A.
Carty, M.P.
Glynn, M.
Maher, M.
Smith, T.
Yao, J.
Dixon, K.
McCann, J.
Rynn, L.
Flanagan, A.
Repository DOI
Publication Date
2003-02-01
Type
Article
Downloads
Citation
Carty, M.P. Glynn, M.; Maher, M.; Smith, T.; Yao, J.; Dixon, K.; McCann, J.; Rynn, L.; Flanagan, A. (2003). The rad30 cancer susceptibility gene. Biochemical Society Transactions 31 , 252-256
Abstract
The human skin cancer-prone disease xeroderma pigmentosum variant (XPV) results from a mutation in RAD30, which encodes the novel lesion bypass DNA polymerase eta. XPV cells are characterized by delayed completion of DNA replication and increased mutagenesis following UV irradiation. in cell-free extracts of XPV lymphoblasts, functional DNA polymerase eta is required for the complete replication of a double-stranded plasmid containing either a single (6-4) photoproduct or a cyclobutane pyrimidine dimer (CPD), the major mutagenic UV-induced lesion. In cultured XPV cells, replication arrest activates downstream signalling pathways, leading to hyperphosphorylation of the 34-kDa subunit of the trimeric single-stranded DNA-binding protein, RPA (replication protein A). Many of the RAD30 mutations identified in XPV cells result in truncation and inactivation of DNA polymerase eta. To examine whether polymorphisms in the RAD30 gene that result in altered polymerase eta function, rather than enzyme inactivation, might contribute to individual susceptibility to skin cancer, methods to screen for sequence changes in the RAD30 gene in human genomic DNA have been developed.
Funder
Publisher
Portland Press Ltd.
Publisher DOI
10.1042/bst0310252
Rights
Attribution-NonCommercial-NoDerivs 3.0 Ireland